drugset / Trial / NCT00927758
Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair
RandomizedCrossoverQuadruple-blindTreatment
Summary
To examine the post-dose changes in exhaled Nitric Oxide (eNO) following treatment with inhaled Advair in subjects with chronic but stable asthma as defined in Global Initiative for Asthma (GINA) guidelines.
Timeline
- Start
- 2009-06
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluticasone propionate | Other / unclassified | 100 ug | Inhaled |
| Comparator | Fluticasone propionate | Other / unclassified | 250 ug | Inhaled |
| Comparator | Fluticasone propionate | Other / unclassified | 500 ug | Inhaled |
| Comparator | Salmeterol | Other / unclassified | 50 ug | Inhaled |